Creo Medical (LON:CREO) Trading Down 0.8%

Creo Medical Limited (LON:CREOGet Rating)’s stock price traded down 0.8% during trading on Friday . The stock traded as low as GBX 74.40 ($0.91) and last traded at GBX 74.40 ($0.91). 7,943 shares were traded during mid-day trading, a decline of 93% from the average session volume of 108,236 shares. The stock had previously closed at GBX 75 ($0.92).

Creo Medical Price Performance

The company has a debt-to-equity ratio of 14.40, a quick ratio of 2.65 and a current ratio of 3.10. The company’s 50 day moving average price is GBX 87.93 and its 200 day moving average price is GBX 107.53. The company has a market cap of £134.82 million and a price-to-earnings ratio of -4.96.

Insider Activity

In related news, insider Charles Spicer purchased 15,435 shares of Creo Medical stock in a transaction that occurred on Thursday, May 26th. The shares were acquired at an average price of GBX 97 ($1.19) per share, for a total transaction of £14,971.95 ($18,345.73).

About Creo Medical

(Get Rating)

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues.

Further Reading

Receive News & Ratings for Creo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical and related companies with MarketBeat.com's FREE daily email newsletter.